COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,678 Articles (22,913 medRxiv, 8,765 bioRxiv)

Most recent first Previous |  Page 953: Articles 9521-9530  | Next

Three-month follow-up of heterologous vs homologous third vaccination in kidney transplant recipients
Heinzel, A., Schrezenmeier, E., Regele, F., Raab, L., Eder, M., Aigner, C., Jabbour, R., Aschauer, C., Stefanski, A.-L., Doerner, T., Budde, K., Reindl-Schwaighofer, R., Oberbauer, R.
10.1101/2022.02.22.22270838 — Posted: 2022-02-24
Gestational SARS-CoV-2 infection is associated with placental expression of immune and trophoblast genes
Lesseur, C., Jessel, R. H., Ohrn, S., Ma, Y., Li, Q., Dekio, F., Brody, R. I., Wetmur, J. G., Gigase, F. A. J., Lieber, M., Lieb, W., Lynch, J., Afzal, O., Ibroci, E., Rommel, A.-S., Janevic, T., Stone, J., Howell, E. A., Galang, R. R., Dolan, S. M., Bergink, V., De Witte, L. D., Chen, J.
10.1101/2022.02.22.22271359 — Posted: 2022-02-24
SARS-CoV-2 Infection Breakthrough among the non-vaccinated and vaccinated: a Real World Evidence study based on Big Data
Perrella, A., BIsogno, M., D'Argenzio, A., Trama, U., Coscioni, E., Orlando, V.
10.1101/2022.02.22.21266830 — Posted: 2022-02-24
SARS-CoV-2 seroprevalence, vaccination, and hesitancy in agricultural workers in Guatemala
Calvimontes, D. M., Krisher, L., Cruz-Aguilar, A., Pilloni-Alessio, D., Crisostomo-Cal, L. E., Castaneda-Sosa, E. A., Butler-Dawson, J., Olson, D., Newman, L. S., Asturias, E. J.
10.1101/2022.02.22.22270907 — Posted: 2022-02-24
Avoiding false positive SARS-CoV-2 rapid antigen test results with point-of-care molecular testing on residual test buffer
LeBlanc, J. J., McCracken, G. R., Goodall, B., Hatchette, T. F., Barrett, L., Ross, J., Davidson, R. J., Patriquin, G.
10.1101/2022.02.18.22271189 — Posted: 2022-02-24
Abdominal Imaging Associates Body Composition with COVID-19 Severity
Basty, N., Sorokin, E. P., Thanaj, M., Srinivasan, R., Whitcher, B., Bell, J. D., Cule, M., Thomas, E. L.
10.1101/2022.02.22.22270091 — Posted: 2022-02-24
Association of Workload and Practice of Respectful Maternity Care Among the Healthcare Providers, Before and During the COVID-19 Pandemic in South Western Nepal: A Cross-Sectional Study
Pokharel, A., Kiriya, J., Shibanuma, A., Silwal, R., Jimba, M.
10.1101/2022.02.21.22271309 — Posted: 2022-02-24
Molnupiravir (MK-4482) is efficacious against Omicron and other SARS-CoV-2 variants in the Syrian hamster COVID-19 model
Rosenke, K., Okumura, A., Lewis, M. C., Feldmann, F., Meade-White, K., Bohler, W. F., Griffin, A., Rosenke, R., Shaia, C., Jarvis, M., Feldmann, H.
10.1101/2022.02.22.481491 — Posted: 2022-02-24
Ivermectin does not protect against SARS-CoV-2 infection in the Syrian hamster model
Foo, C. S.-Y., Abdelnabi, R., Vangeel, L., De Jonghe, S., Jochmans, D., Weynand, B., Neyts, J.
10.1101/2022.02.22.481472 — Posted: 2022-02-24
SARS-CoV-2 peptide vaccine elicits T-cell responses in mice but does not protect against infection or disease
Baxter, V. K., Anderson, E. J., Taft-Benz, S. A., Olsen, K. S., Sambade, M., Gentry, K. M., Beck, W. A., Garness, J., Woods, A., Fini, M., Carpenter, B., Smith, C. C., Heise, M. T., Vincent, B. G., Rubinsteyn, A.
10.1101/2022.02.22.481499 — Posted: 2022-02-24

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).